Close

Articles Posted in Defective Drugs

Updated:

Xarelto Reported Side Effects Of Brain Bleeds And Strokes And Even Death Has Lead To Lawsuits

The blood thinner Xarelto was introduced in 2011 by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and Bayer Health Care. The prescribed medication is used by millions of Americans nationwide as a way to reduce the risk of stroke. Xarelto may also be prescribed to reduce the risk of…

Updated:

Nearly 2,200 Lipitor Cases Filed Over Type 2 Diabetes Side Effects

The number of drug injury lawsuits against Pfizer Inc. over its Lipitor medication continues to rise. Court documents indicate that in U.S. District Court, District of South Carolina, where federal multidistrict litigation is taking place, at least 2,185 Lipitor cases are pending. In their Lipitor lawsuits, the plaintiffs contend that…

Updated:

State Superior Court Upholds $11M Topamax Injury Verdict Against Janssen Pharmaceuticals

According to a state superior court, the parents of a child who sustained serious birth defects because the mother took Topamax while she was pregnant is entitled to $11.6 million from Johnson & Johnson’s Janssen Pharmaceuticals. The ruling strike’s down Janssen’s appeal to an earlier jury verdict. The child’s mother,…

Updated:

Lipitor Injury Lawsuits Against Pfizer Blame the Drug for Diabetes

More women are continuing to come forward, accusing pharmaceutical company Pfizer of not giving them proper warning that taking cholesterol drug Lipitor might cause them to develop type 2 diabetes. In their Lipitor diabetes lawsuits, the plaintiffs claims that the drug manufacturer was aware of these side effects but did…

Updated:

Paxil Birth Defect Lawsuit Is Sent Back to State Court

The United States Court of Appeals for the Third Circuit has ordered that a drug defect lawsuit against GlaxoSmithKline LLC over its Paxil antidepressant medication be sent back to a state court. The three-judge panel ruled that the second removal to federal court was not timely. They said that Pennsylvania’s…

Updated:

German Drug Maker Agrees to Pay $650M to Settle Pradaxa Claims

German pharmaceutical company Boehringer Ingelheim has agreed to pay $650 million to settle thousands of consumer lawsuits involving its blood thinner medication Pradaxa. The company issued a statement Wednesday to publicize its agreement, which will most likely settle the majority of the 4,000 cases brought against the company by patients…

Updated:

Boehringer Ingelheim Settles Over 4,000 Pradaxa Drug Injury Lawsuits for $650M

Boehringer Ingelheim says that it will pay $650 million to resolve more than 4,000 drug defect cases involving Pradaxa, its anticoagulant. Despite settling, the drug manufacturer is denying any wrongdoing. Pradaxa has been named in numerous incidents involving excessive bleeding complications. The U.S. Food and Drug Administration has received notice…

Contact Us
Start Chat